These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37877)

  • 1. beta-Adrenoceptor-blocking agents and the kidney: effect of nadolol and propranolol on the renal circulation.
    Hollenberg NK; Adams DF; McKinstry DN; Williams GH; Borucki LJ; Sullivan JM
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):219S-225S. PubMed ID: 37877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of arotinolol on hemodynamics and adrenergically induced renin release and renal vasoconstriction.
    Suzuki-Kusaba M; Hisa H; Kimura T; Satoh S
    Arzneimittelforschung; 1988 May; 38(5):671-7. PubMed ID: 2458109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the effects of intravenous propranolol and nadolol on the renal response to hypertonic saline infusion.
    Waller DG; Mihindukulasuriya J; Warren DJ
    Br J Clin Pharmacol; 1985 Jan; 19(1):37-43. PubMed ID: 2858216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of propranolol and nadolol on renal blood flow in normal rats and rats with congestive heart failure.
    Brenner BM; Duchin KL; Ichikawa I; Pfeffer J; Pfeffer M
    Am Heart J; 1984 Oct; 108(4 Pt 2):1144-7. PubMed ID: 6148876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of cardiodepressant potency of nadolol, alprenolol, propranolol and pindolol, beta-blocking agents, in heart-lung preparation and blood-perfused excised papillary muscle preparation of the dog.
    Ono H; Kanazawa Y; O'Hara N; Hashimoto K
    Jpn J Pharmacol; 1984 Dec; 36(4):507-17. PubMed ID: 6151997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-adrenoceptor blocking effects and pharmacokinetics of betaxolol (SL 75212) in man.
    Giudicelli JF; Chauvin M; Thuillez C; Richer C; Bianchetti G; Gomeni R; Morselli PL
    Br J Clin Pharmacol; 1980 Jul; 10(1):41-9. PubMed ID: 6104973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic carvedilol reduces mortality and renal damage in hypertensive stroke-prone rats.
    Barone FC; Nelson AH; Ohlstein EH; Willette RN; Sealey JE; Laragh JH; Campbell WG; Feuerstein GZ
    J Pharmacol Exp Ther; 1996 Nov; 279(2):948-55. PubMed ID: 8930204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional hemodynamic effects of the beta-adrenoceptor blockers tertatolol and propranolol in conscious spontaneously hypertensive rats.
    Nievelstein HM; Tijssen CM; Smits JF; Struyker-Boudier HA
    Arch Int Pharmacodyn Ther; 1986 Jul; 282(1):118-29. PubMed ID: 2876684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nadolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.
    Heel RC; Brogden RN; Pakes GE; Speight TM; Avery GS
    Drugs; 1980 Jul; 20(1):1-23. PubMed ID: 6105067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta blockers and renal function: a reappraisal.
    Epstein M; Oster JR
    J Clin Hypertens; 1985 Mar; 1(1):85-99. PubMed ID: 2873206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of beta-adrenoceptors mediating renin release produced by isoproterenol in conscious dogs.
    Himori N; Izumi A; Ishimori T
    Am J Physiol; 1980 May; 238(5):F387-93. PubMed ID: 6103674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of propranolol and ICI 66082 in blocking the renin releasing effect of renal nerve stimulation in the cat.
    Johns EJ; Singer B
    Br J Pharmacol; 1974 Oct; 52(2):315-8. PubMed ID: 4155994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta blockers induce different intrarenal effects in humans: demonstration by selective infusion of tertatolol and propranolol.
    Nitenberg A; Chemla D; Blanchet F; Guery O; Prost JF; Dutray-Dupagne C
    J Clin Pharmacol; 1990 Oct; 30(10):930-7. PubMed ID: 1977772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative beta-adrenoceptor blocking effect and pharmacokinetics of bucindolol and propranolol in man.
    Maury M; Berdeaux A; Kher A; Duhaze P; Giudicelli JF
    Eur J Clin Pharmacol; 1985; 27(6):649-56. PubMed ID: 2859199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of beta-adrenoceptor antagonists and thyroid hormones in the control of heart rate in the dog.
    Allely MC; Ungar A
    Br J Pharmacol; 1985 Oct; 86(2):393-8. PubMed ID: 2864972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between beta-blockade, hyporeninaemic and hypotensive effect of two beta-blocking agents.
    Amery A; De Plaen JF; Fagard R; Linjen P; Reybrouck T
    Postgrad Med J; 1976; 52 Suppl 4():102-8. PubMed ID: 9626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive and renal effects of tertatolol, a new beta-blocking agent, in hypertensive patients.
    Salvetti A; Leonetti G; Bernini GP; Rupoli L; Lucarini AR; Sangiorgio P; Mauro M; Di Stratis P; Zanchetti A
    Am J Nephrol; 1986; 6 Suppl 2():45-9. PubMed ID: 2879473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term renal vasodilator effect of the beta-adrenoceptor blocker tertatolol in conscious spontaneously hypertensive rats.
    Nievelstein HN; Tyssen CM; Smits JF; Struyker-Boudier HA
    J Cardiovasc Pharmacol; 1988 Aug; 12(2):252-4. PubMed ID: 2459558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged effect of nadolol on heart rate in hyperthyroidism.
    Adam RD; Parekh P; Harrower AD
    Curr Med Res Opin; 1981; 7(4):212-4. PubMed ID: 6112117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of kinetic interactions of nadolol and propranolol with cimetidine.
    Duchin KL; Stern MA; Willard DA; McKinstry DN
    Am Heart J; 1984 Oct; 108(4 Pt 2):1084-6. PubMed ID: 6148867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.